Study Stopped
Suspended since april 2020 as the application is temporarily unavailable
Toi Même: a Mobile System for Measuring Bipolar Illness
1 other identifier
interventional
36
1 country
3
Brief Summary
Bipolar disorder is a severe psychiatric illness with chronic course and it is associated with high risk of relapse and hospitalisation, and many patients do not recover to their previous psychosocial functioning. Major reasons for poor outcomes are delayed intervention for prodromal mood and behavioural symptoms as well as incomplete treatment responses. Current diagnostic approaches used to assess mood symptoms rely on symptom-based categories, which lack sensitivity to detect subtle mood and behavioural changes. Therefore, the ability to better characterizing bipolar patients may allow to detect possible differences in the illness activity. On the other hand, there is a growing interest in the potential use of mobile technologies such as mobile apps, smartphone and internet in psychiatric care. Some projects have been testing the potential benefits of mobile apps to assess and treat individuals at-risk or suffering from mood and bipolar disorders, using online signs and symptoms monitoring, yet to the investigators knowledge, none of them have integrated a dimensional approach in a smartphone app to assess mood and behavioural alterations and bipolar illness activity, including subjective and objective data (e.g. physical activity, social activity, etc.). In this feasibility study the investigators will evaluate the potential relevance of Toi Même app to self-monitoring mood and behavioural changes in bipolar patients with different mood phases compared to the gold-standard mood rating tools used in clinical practice. All patients will be followed for 3 months, with outcome assessments after 2 weeks, after 1 month, 2 months and after 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2017
CompletedStudy Start
First participant enrolled
April 12, 2018
CompletedFirst Posted
Study publicly available on registry
April 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedDecember 19, 2023
December 1, 2023
2.7 years
November 17, 2017
December 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Severity of depressive symptoms
Changes in depressive symptoms measured using the Montgomery-Asberg Depression Rating Scale during the 3 months study period.
3 months study period
Severity of manic symptoms
Changes in manic symptoms measured using the Young Mania Rating Scale during the 3 months study period.
3 months study period
Secondary Outcomes (8)
Self-rated depressive symptoms
3 months study period
Self-rated manic symptoms
3 months study period
Activation levels
3 months study period
Treatment adherence
3 months study period
Functional impairment
3 months study period
- +3 more secondary outcomes
Study Arms (1)
Toi Même plus treatment as usual
EXPERIMENTALOne-Arm study Intervention: Toi Même self-monitoring smartphone application plus treatment as usual which includes pharmacological and/or psychological treatment. Tool: Toi Même mobile app
Interventions
Toi Même self-monitoring smartphone application plus treatment as usual which includes pharmacological and/or psychological treatment.
Eligibility Criteria
You may qualify if:
- patients with the current diagnosis of Bipolar disorder type I or type II according to the DSM-5 criteria
- having an iPhone with iOS version from 9.x with access to wireless Internet connectivity.
You may not qualify if:
- Current DSM-5 diagnosis of schizophrenia, psychotic disorders, dementia, or mental retardation.
- Active suicidal ideation or behaviours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Pasteurlead
Study Sites (3)
Nightingale Hospitals Paris - Clinique du Château
Garche, 92380, France
Centre Thérapeutique et Preventif de Jour - Troubles Bipolaires (Clinique Bellevue)
Meudon, Île-de-France Region, 92190, France
Centre Hospitalier Sainte Anne
Paris, Île-de-France Region, 75014, France
Related Publications (1)
Dargel AA, Mosconi E, Masson M, Plaze M, Taieb F, Von Platen C, Buivan TP, Pouleriguen G, Sanchez M, Fournier S, Lledo PM, Henry C. Toi Meme, a Mobile Health Platform for Measuring Bipolar Illness Activity: Protocol for a Feasibility Study. JMIR Res Protoc. 2020 Aug 18;9(8):e18818. doi: 10.2196/18818.
PMID: 32638703DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chantal Henry, MD PhD
Institut Pasteur
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2017
First Posted
April 25, 2018
Study Start
April 12, 2018
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
December 19, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share